KM
Therapeutic Areas
Avstera Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AVS100 | Locally advanced or metastatic solid tumors | Phase 1 |
| Next-Gen Oral HDAC6i | Cardiometabolic & Cardiovascular diseases | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| AVS100 | Locally advanced or metastatic solid tumors | Phase 1 |
| Next-Gen Oral HDAC6i | Cardiometabolic & Cardiovascular diseases | Preclinical |